Based on the robust results, we are are confident of achieving our full-year objectives for new record sales and earnings.

Our increased level of investment in marketing and sales, with the priority on key growth drivers, resulted in a sales growth of 21 percent in Pharmaceuticals in the U.S.,

We are confident of delivering in 2006 another year of dynamic growth with record sales and earnings.

We first want to fix the quality and quantity problems which are at hand.

If you can't find the human resources in Europe you go elsewhere. As a European, I'm concerned for Europe.

Looking ahead, we anticipate a somewhat softer third quarter and, again, a more dynamic fourth quarter resulting in mid-single-digit sales growth... and solid operating growth for the full year,